Advanced Search
Latest accepted have been peer-reviewed and accepted, which are not yet assigned to volumes /issues, but are citable by Digital Object Identifier (DOI).
Articles in press have been peer-reviewed and accepted, which are not yet assigned to volumes /issues, but are citable by Digital Object Identifier (DOI).
Advances in intracerebral drug delivery technology and therapeutic strategies for brain diseases
ZHANG Huaqing, DING Yang
2024, 55(5): 573-576. DOI: 10.11665/j.issn.1000-5048.2024092502
Abstract PDF
Drug delivery strategies and clinical research progress for encephalopathy
LU Ningshu, JI Tao, LU Yinglan, XU Xiyuan, GU Xiaochen, DING Yang
2024, 55(5): 577-589. DOI: 10.11665/j.issn.1000-5048.2024063001
Abstract PDF
Research progress of blood-brain barrier crossing strategies and brain-targeted drug delivery mediated by nano-delivery system
YE Zhenning, WU Zhenghong, ZHANG Huaqing
2024, 55(5): 590-602. DOI: 10.11665/j.issn.1000-5048.2024052202
Abstract PDF
Research advances in modulating microglia for intervening in Alzheimer’s disease
CHANG Yuan, MAGETA Mageta Samwel, LI Nibowen, TANG Yingqi, LI Huangjuan, QIAN Chenggen
2024, 55(5): 603-612. DOI: 10.11665/j.issn.1000-5048.2024030201
Abstract PDF
Advances in anti-Alzheimer’s disease nano drug delivery system based on pathogenic mechanism of ferroptosis
SU Haiying, WANG Yukun, LI Weisong, ZHOU Jianping, CHENG Hao
2024, 55(5): 613-623. DOI: 10.11665/j.issn.1000-5048.2024040702
Abstract PDF
Drug delivery systems for sensitization of glioblastoma radiotherapy
LIU Mingxuan, GUO Yun, SUN Tao
2024, 55(5): 624-633. DOI: 10.11665/j.issn.1000-5048.2024050401
Abstract PDF
Synthesis and antitumor activity of heteroatom-substituted azulenes derivatives of 1,2-benzothiazine
ZHAO Xiaomei, WANG Xin, JI Xia, Zhang Jing, ZHANG Hua, HU Guoqiang
2024, 55(5): 634-638. DOI: 10.11665/j.issn.1000-5048.2023120503
Abstract PDF
Sesquiterpenoid glycosides from the aerial parts of Sarcandra glabra
LI Qianqian, WANG Nan, LUO Jun
2024, 55(5): 639-644. DOI: 10.11665/j.issn.1000-5048.2024052203
Abstract PDF
Chemical synthesis and antibody affinity of epitope fragments from Helicobacter pylori lipopolysaccharide
ZHAO Hui, ZOU Xiaopeng, XIAO Lei, HU Jing, YIN Jian
2024, 55(5): 645-656. DOI: 10.11665/j.issn.1000-5048.2024031201
Abstract PDF
Design, preparation, and antitumor activity of fusion protein vaccine based on tumor antigen PBK
QIAN Qianqian, LI Guozhi, TIAN Hong, GAO Xiangdong
2024, 55(5): 657-665. DOI: 10.11665/j.issn.1000-5048.2024030801
Abstract PDF
Genetic engineering and molecular modification of recombinant fully humanized single-domain antibody against Helicobacter pylori UreB
WANG Xuefang, ZHAO Yang, LIU Zhuqing, GUO Le, ZHONG Feiliang, LUO Xuegang
2024, 55(5): 666-672. DOI: 10.11665/j.issn.1000-5048.2023122903
Abstract PDF
Research progress of nitroxide radical derivatives and their biological activities
ZHANG Qili, TIAN Xue, WANG Jie, ZHAO Lei, XIA Pengfei, XU Yanli, XU Fumei, JIA Yinqiang
2024, 55(5): 673-684. DOI: 10.11665/j.issn.1000-5048.2023041902
Abstract PDF
Research progress of lysine specific demethylase 1 (LSD1) inhibitors
ZHANG Xiaomeng, FU Jinyang, HE Yanan, GONG Jianhong, DU Kun, WU Ya, ZHI Yanle
2024, 55(5): 685-696. DOI: 10.11665/j.issn.1000-5048.2023100701
Abstract PDF
Research advances in microsomal prostaglandin E2 synthase-1 targeted anti-inflammatory drugs
JI Shuang, CHEN Lihong
2024, 55(5): 697-707. DOI: 10.11665/j.issn.1000-5048.2023032001
Abstract PDF
Blood coagulation factor XI: new strategy of targeted anticoagulant therapy
HOU Kai, LI Ping, ZHANG Jinlian, WANG Fang, YANG Yu
2024, 55(5): 708-714. DOI: 10.11665/j.issn.1000-5048.2023050101
Abstract PDF
Development and application of chemical reference materials
FENG Yanchun, PEI Wenli, NING Baoming, SHI Jifeng
2024, 55(5): 715-720. DOI: 10.11665/j.issn.1000-5048.2023122402
Abstract PDF

Special Issues

More+

Total visits：